🏛️ Verified NIH Protocol • Sourced via U.S. National Library of Medicine (Last Synced: 2026-06-23)

Real-world Secukinumab Outcomes in Canadian HS Patients

🟢 Recruiting Not Applicable 📊 Observational Clinical Research Sponsor: Novartis Pharmaceuticals

🩺 Protocol Summary

The HS-RISE study aims to assess real-world HS treatment outcomes and patterns, safety of secukinumab, and to describe the baseline characteristics of patients diagnosed with moderate-to- severe HS who are prescribed secukinumab in Canadian routine clinical practice.

Primary Research Facility: Novartis Investigative Site (Calgary, Alberta)

📋 Basic Study Criteria & Logistics Checklist

0 of 3 Checked

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Hidradenitis Suppurativa?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged between 18 Years and 100 Years?

🔍 Protocol Specified Age Range: 18 Years to 100 Years

Able to attend required in-person clinic visits and study procedures at one of the participating study centers?

🔍 Logistical Requirement: 15 Registered Participating Sites

📍 Primary Site Map

Site: Novartis Investigative Site — Calgary, Alberta

📍 All Participating Trial Locations (15 Sites)

Multi-Center Trial

This protocol is enrolling participants across multiple clinical centers:

1. Novartis Investigative Site — Calgary, Alberta

2. Novartis Investigative Site — Calgary, Alberta

3. Novartis Investigative Site — Winnipeg, Manitoba

4. Novartis Investigative Site — Fredericton, New Brunswick

5. Novartis Investigative Site — St. John's, Newfoundland and Labrador

6. Novartis Investigative Site — Cobourg, Ontario

7. Novartis Investigative Site — Hamilton, Ontario

8. Novartis Investigative Site — London, Ontario

9. Novartis Investigative Site — Markham, Ontario

10. Novartis Investigative Site — Mississauga, Ontario

11. Novartis Investigative Site — Richmond Hill, Ontario

12. Novartis Investigative Site — Toronto, Ontario

13. Novartis Investigative Site — Saint-Jérôme, Quebec

14. Novartis Investigative Site — Sherbrooke, Quebec

15. Novartis Investigative Site — Saskatoon, Saskatchewan

📄 Print Doctor Discussion Sheet

Preview and print a 1-page summary with 5 tailored questions for your physician.

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.

🏛️ Official Government Provenance

NIH ClinicalTrials.gov Protocol Record

NCT Identifier: NCT07282015 • Last Synced: 2026-06-23

View on ClinicalTrials.gov ↗